The Association between Use of Renin-Angiotensin-Aldosterone System Inhibitors and the Risk and Mortality of Pancreatic Cancer: A Systematic Review and Meta-Analysis

CONCLUSION: In summary, while renin-angiotensin-aldosterone system inhibitors did not appear to impact PC risk, their use was associated with lower PC mortality based on this meta-analysis of the current evidence. More rigorous and well-designed studies are required to validate and support these findings.PMID:38629353 | DOI:10.2174/0127724328291047240409062436

Source: Pharmacological Reviews - April 17, 2024 Category: Drugs & Pharmacology Authors: Rasoul Rahimi Seyed Mahmood Reza Hashemi Rafsanjani Saeid Heidari-Soureshjani Catherine Mt Sherwin Karamali Kasiri Source Type: research